Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Select Medical Holdings Corporation (SEM) vs Veritone Inc (VERI) Price & Performance

Select Medical Holdings CorporationTrade
Veritone IncTrade

Price performance (Past 24H)

Key statistics

Select Medical Holdings Corporation vs Veritone Inc — how do they compare? Select Medical Holdings Corporation trades at $16.51 (market cap $2.05B), while Veritone Inc trades at $1.12 (market cap $97.60M). The key difference: Select Medical Holdings Corporation is far larger — about 21× Veritone Inc's market cap, and Select Medical Holdings Corporation pays a 1.51% dividend while Veritone Inc pays none. Which is the better fit depends on your goals.

SEMVERI
Market Cap
$2.05B$97.60M
Sector
HealthTechnology
52-Week High
$16.66$8.39
52-Week Low
$11.77$1.02
Enterprise Value
$5.01B$129.63M
Dividend Yield
1.51%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Select Medical Holdings Corporation

Select Medical Holdings Corporation (SEM) trades at $16.51, unchanged on the day, following its recent acquisition completion by a consortium led by Robert A. Ortenzio and Martin F. at $16.50 per share. The stock exhibits a mixed technical picture with a bullish overall signal but bearish moving averages. Fundamentally, the company reported 2025 revenue of $5.45 billion with a net income margin of 2.42%, while valuation ratios like a P/E of 15.43 and P/S of 0.36 appear reasonable. Recent earnings show two misses in the last three quarters against expectations.

The investment outlook is dominated by the completed acquisition, effectively capping upside near the $16.50 deal price. Risks include ongoing shareholder litigation alleging fiduciary breaches by the board regarding the buyout fairness. Analyst sentiment is neutral with a Hold-heavy consensus, while the stock's future price action will largely hinge on legal outcomes surrounding the acquisition terms rather than operational performance.

Veritone Inc

VERI trades at $1.05, up 2.94% on the day, but remains in a bearish technical trend. The company reported a net loss of $111.73 million in 2025, with a negative net income margin of -123.76%, while revenue declined to $92.19 million. Multiple securities class action lawsuits, with a July 20, 2026 deadline, highlight significant legal and reputational risks stemming from alleged improper revenue accounting.

The outlook is highly speculative given severe profitability challenges and ongoing litigation. Analyst consensus is split between Buy and Hold, but fundamental weaknesses and legal overhangs present substantial downside risk. Investment suitability is limited to risk-tolerant investors monitoring resolution of legal issues and a path to profitability.

Returns comparison

Trailing returns across standard periods

About Select Medical Holdings Corporation

Select Medical Holdings Corporation is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's services focus on treating patients with serious illnesses, injuries, and post-acute care needs. SEM provides specialized care across various settings, aiming to help patients recover and return home.

Read more on SEM

About Veritone Inc

Veritone is a leading provider of enterprise AI software and solutions, centered on its proprietary AI operating system, aiWARE™. The platform orchestrates a vast ecosystem of machine learning models to transform unstructured data—such as audio, video, and text—into actionable intelligence. Serving the media, entertainment, and public sectors, Veritone is a critical infrastructure partner for organizations looking to monetize data archives and operationalize AI at scale.

Read more on VERI